ALC:NYE-Alcon AG (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 78.77

Change

0.00 (0.00)%

Market Cap

USD 38.91B

Volume

1.12M

Analyst Target

USD 65.36
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

N/A

USD 68.11B
HYB New America High Income Closed..

N/A

USD 35.93B
RMD ResMed Inc

N/A

USD 31.27B
WST West Pharmaceutical Services I..

N/A

USD 27.24B
BAX Baxter International Inc

N/A

USD 18.19B
ATR AptarGroup Inc

N/A

USD 9.84B
TFX Teleflex Incorporated

N/A

USD 9.61B
STVN Stevanato Group SpA

N/A

USD 7.29B
BLCO Bausch + Lomb Corp

N/A

USD 5.42B
HAE Haemonetics Corporation

N/A

USD 4.83B

ETFs Containing ALC

CAPE:LSE Ossiam Shiller Barclays C.. 5.72 % 0.00 %

N/A

USD 0.17B
CHSRI:SW UBS ETF (CH) - MSCI Switz.. 5.23 % 0.00 %

N/A

USD 0.55B
CHSRIA:SW UBS ETF (CH) MSCI Switzer.. 5.23 % 0.00 %

N/A

USD 0.32B
CHSR:XETRA UBS(Lux)Fund Solutions .. 5.21 % 0.00 %

N/A

USD 0.17B
CHSRII:SW UBS(Lux)Fund Solutions .. 4.98 % 0.00 %

N/A

USD 0.30M
EL4X:F Deka DAXplus Maximum Divi.. 4.38 % 0.00 %

N/A

USD 0.29B
EL4X:XETRA Deka DAXplus Maximum Divi.. 4.38 % 0.00 %

N/A

USD 0.29B
DXS0:F Xtrackers - SLI UCITS ETF 4.32 % 0.00 %

N/A

USD 0.27B
DXS0:XETRA Xtrackers SLI UCITS ETF 1.. 4.32 % 0.00 %

N/A

USD 0.26B
XSLI:SW Xtrackers SLI UCITS ETF 1.. 4.32 % 0.00 %

N/A

USD 0.27B
SLICHA:SW UBS ETF (CH) – SLI® (C.. 4.30 % 0.00 %

N/A

USD 1.04B
EXI1:F iShares SLI UCITS ETF (DE.. 4.28 % 0.00 %

N/A

USD 0.37B
EXI1:XETRA iShares SLI UCITS ETF (DE.. 4.28 % 0.00 %

N/A

USD 0.37B
CSSLI:SW iShares SLI® ETF (CH) 4.27 % 0.00 %

N/A

USD 0.56B
CBCH30:SW 3.78 % 0.00 %

N/A

N/A
C030:F Lyxor DJ Switzerland Tita.. 3.64 % 0.00 %

N/A

USD 0.01B
FTGG:F First Trust Global Funds .. 3.23 % 0.00 %

N/A

USD 6.77M
XSDR:LSE Xtrackers MSCI Europe Hea.. 2.66 % 0.00 %

N/A

USD 0.15B
DXSE:XETRA Xtrackers - Stoxx Europe .. 2.66 % 0.00 %

N/A

USD 0.14B
CBUF:XETRA iShares MSCI World Health.. 2.63 % 0.00 %

N/A

USD 1.13B
EXV5:F iShares STOXX Europe 600 .. 2.60 % 0.00 %

N/A

USD 0.15B
EXV5:XETRA iShares STOXX Europe 600 .. 2.60 % 0.00 %

N/A

USD 0.15B
ESIH:F Ishares VI PLC - Ishares .. 2.43 % 0.00 %

N/A

USD 0.60B
ESIH:XETRA iShares MSCI Europe Healt.. 2.43 % 0.00 %

N/A

USD 0.60B
STWX:SW SPDR® MSCI Europe Health.. 2.43 % 0.00 %

N/A

USD 0.66B
ESIH:LSE iShares MSCI Europe Healt.. 2.36 % 0.00 %

N/A

USD 0.60B
SXDPEX:SW iShares STOXX Europe 600 .. 2.31 % 0.00 %

N/A

USD 0.44B
HLTH:LSE SPDR® MSCI Europe Health.. 2.29 % 0.00 %

N/A

USD 0.65B
STW:PA SPDR® MSCI Europe Health.. 2.29 % 0.00 %

N/A

USD 0.67B
SPYH:F SSgA SPDR ETFs Europe II .. 2.29 % 0.00 %

N/A

USD 0.67B
SPYH:XETRA SPDR® MSCI Europe Health.. 2.29 % 0.00 %

N/A

USD 0.66B
HEAE:LSE SPDR® MSCI Europe Health.. 2.29 % 0.00 %

N/A

USD 0.66B
EXV4:F iShares STOXX Europe 600 .. 2.17 % 0.00 %

N/A

USD 0.71B
EXV4:XETRA iShares STOXX Europe 600 .. 2.17 % 0.00 %

N/A

USD 0.70B
EWL iShares MSCI Switzerland .. 0.00 % 0.47 %

N/A

USD 1.01B
FGM First Trust Germany Alpha.. 0.00 % 0.80 %

N/A

USD 9.82M
LNGR 0.00 % 0.50 %

N/A

N/A
RNDM 0.00 % 0.65 %

N/A

N/A
FLSW Franklin FTSE Switzerland.. 0.00 % 0.09 %

N/A

USD 0.04B
UC93:LSE UBS MSCI Switzerland 20/3.. 0.00 % 0.00 %

N/A

USD 7.92M
UC94:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.06B
DBXS:F Xtrackers - Switzerland U.. 0.00 % 0.00 %

N/A

USD 1.20B
DXSE:F Xtrackers Stoxx Europe 60.. 0.00 % 0.00 %

N/A

USD 0.15B
C030:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.13B
DBXS:XETRA Xtrackers - Switzerland U.. 0.00 % 0.00 %

N/A

USD 1.34B
FTGG:XETRA First Trust Germany Alpha.. 0.00 % 0.00 %

N/A

USD 6.77M
1391:TSE 0.00 % 0.00 %

N/A

N/A
CHSPI:SW iShares Core SPI® ETF (C.. 0.00 % 0.00 %

N/A

USD 3.08B
CSSMI:SW iShares SMI® ETF (CH) 0.00 % 0.00 %

N/A

USD 2.00B
SMICHA:SW UBS ETF (CH) – SMI® (C.. 0.00 % 0.00 %

N/A

USD 2.48B
SPICHA:SW UBS ETF (CH) – SPI® (C.. 0.00 % 0.00 %

N/A

USD 1.45B
SW2CHA:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.43B
SW2CHB:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 1.38B
SW2UKD:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.03B
SWICHA:SW UBS ETF (CH) – MSCI Swi.. 0.00 % 0.00 %

N/A

USD 0.78B
SWUSAH:SW UBS ETF (CH) – MSCI Swi.. 0.00 % 0.00 %

N/A

USD 0.38B
XSMC:SW Xtrackers Switzerland UCI.. 0.00 % 0.00 %

N/A

USD 0.44B
XSMI:SW Xtrackers Switzerland UCI.. 0.00 % 0.00 %

N/A

USD 1.20B
CEFA Global X S&P Catholic Val.. 0.00 % 0.00 %

N/A

USD 0.02B
AGNG Global X Aging Population.. 0.00 % 0.00 %

N/A

USD 0.06B
CHEUR:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.17B
CHEURD:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 4.07M
CHUSD:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.08B
CHUSDD:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.01B
S2HGBD:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.23M
SMIEX:SW iShares SLI UCITS ETF (DE.. 0.00 % 0.00 %

N/A

USD 5,933.96B
SWEUAH:SW UBS ETF (CH) – MSCI Swi.. 0.00 % 0.00 %

N/A

USD 0.13B
S2HGBA:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 7.92M

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.83% 56% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.83% 50% F 42% F
Trailing 12 Months  
Capital Gain 8.68% 78% C+ 58% F
Dividend Return 0.31% 22% F 3% F
Total Return 8.99% 78% C+ 51% F
Trailing 5 Years  
Capital Gain 37.18% 73% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.18% 73% C 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 9.43% 56% F 69% C-
Dividend Return 9.64% 56% F 64% D
Total Return 0.21% 11% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 17.52% 89% A- 62% D
Risk Adjusted Return 55.00% 89% A- 79% B-
Market Capitalization 38.91B 94% A 93% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.